ABG Innovation Capital Partners III GP Ltd - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 123 filers reported holding PULMONX CORP in Q3 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.

Quarter-by-quarter ownership
ABG Innovation Capital Partners III GP Ltd ownership history of PULMONX CORP
ValueSharesWeighting
Q4 2021$93,000
-42.9%
2,901
-35.8%
5.38%
-20.6%
Q3 2021$163,000
-18.1%
4,5210.0%6.77%
+916.8%
Q2 2021$199,000
-99.5%
4,521
-99.5%
0.67%
-96.4%
Q1 2021$38,117,000
-33.7%
833,3330.0%18.73%
-44.7%
Q4 2020$57,517,000833,33333.86%
Other shareholders
PULMONX CORP shareholders Q3 2021
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 60,204$886,0003.13%
PURA VIDA INVESTMENTS, LLC 1,327,065$19,534,0001.13%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,465,901$51,018,0001.05%
NEXT CENTURY GROWTH INVESTORS LLC 453,098$6,669,0000.87%
Novo Holdings A/S 510,555$7,515,0000.37%
Rock Springs Capital Management LP 702,400$10,339,0000.30%
RTW INVESTMENTS, LP 691,255$10,175,0000.26%
TimesSquare Capital Management, LLC 1,214,204$17,873,0000.25%
FORMULA GROWTH LTD 54,951$809,0000.22%
Champlain Investment Partners, LLC 2,129,760$31,350,0000.20%
View complete list of PULMONX CORP shareholders